How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Coinbase co-founder and CEO Brian Armstrong joins Yahoo Finance Executive Editor Brian Sozzi to explain how they're building ...

Since Claude Code, its software-engineering agent, launched in February 2025, it has become indispensable for many human ...

ReactOS open source Windows clone ran Half-Life in-game for the first time in 30 years of development. A March 2026 GPU ...

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...

They explore how automation, AI, and integrated platforms are helping finance teams tackle today’s biggest challenges, from ...

The super app is the oldest trick in the technology playbook. OpenAI is staking its IPO valuation on AI to make it work.

Would I recommend replacing Pi-hole with Unbound?

Detailed price information for Health Discovery Corp (HDVY) from The Globe and Mail including charting and trades.

Recently, the concept of so-called covenants has received renewed attention as Bitcoin development and protocol discussions underwent a renaissance. Covenants could enable and facilitate a wide range ...